Jørgensen, K. K., Goll, G. L., Sexton, J., Bolstad, N., Olsen, I. C., Asak, Ø., . . . Jahnsen, J. (2020). Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials. BioDrugs.
Styl cytowania ChicagoJørgensen, Kristin K., et al. "Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease After Switching From Originator Infliximab: Exploratory Analyses From the NOR-SWITCH Main and Extension Trials." BioDrugs 2020.
Styl cytowania MLAJørgensen, Kristin K., et al. "Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease After Switching From Originator Infliximab: Exploratory Analyses From the NOR-SWITCH Main and Extension Trials." BioDrugs 2020.